Medication info
Fabirazole 20 mg (Rabeprazole Sodium)

Fabirazole 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
Pale yellow round enteric-coated tablet
Packaging
28 tablets (14 tablets/AluAlu pack x 2)
Approval status
Active

MFDS item code 201400422 · Approved 2014.01.29 · Insurance code 652604140

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (gastric and duodenal, etc.), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric ulcer, duodenal ulcer: The usual dose for adults is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not resolved after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily dose is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended that this drug 20 mg be administered concomitantly with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted according to each patient's needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily; the 120 mg dose is divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (gastric and duodenal, etc.), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat ulcers that occur in the stomach and duodenum. It also alleviates symptoms of erosive or ulcerative gastroesophageal reflux disease and aids in the long-term maintenance therapy of the condition. It is effective in combination therapy with antibiotics for patients with gastrointestinal ulcers caused by Helicobacter pylori infection. It is also effectively used for special gastric acid hypersecretion disorders such as Zollinger-Ellison syndrome. It is used to treat and improve symptoms associated with various gastrointestinal-related diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual dose for adults is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not resolved after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily dose is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended that this drug 20 mg be administered concomitantly with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted according to each patient's needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily; the 120 mg dose is divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.

Precautions

This medication should not be administered to patients with specific allergic reactions. For example, individuals who are hypersensitive to this drug, its components, or the benzimidazole class should not take it. Additionally, people who are allergic to penicillin or macrolide antibiotics should use this medication cautiously, especially when undergoing combination therapy aimed at eradicating Helicobacter pylori, and should consult a physician. This medication may interact with certain specific drugs, so it is essential to inform your physician about any medications you are currently taking. For example, do not use this medication if you are taking terfenadine, cisapride, pimodipine, astemizole, atazanavir, rilpivirine, and others. Women who are pregnant or breastfeeding should not take this medication, as it can affect the fetus or newborn. Patients with poor liver function or elderly individuals should exercise more caution when using this medication, and those with a history of drug allergies need to be careful. The drug contains a dye called yellow #4 (tartrazine), so caution is necessary for those allergic to this substance. During use, allergic symptoms such as skin rash, hives, and itching may occur; if such symptoms arise, discontinue use immediately and consult a physician. Regular blood tests and liver function tests are required; if abnormalities are found, discontinue the medication and receive appropriate treatment. Patients with cardiovascular issues, gastrointestinal symptoms, neurological symptoms, or respiratory symptoms may experience severe symptoms, and consultation with a physician is essential if this occurs. Long-term use of this medication may increase the risk of fractures related to osteoporosis, so bone density management is necessary during prolonged administration. Also, this medication suppresses gastric acid secretion and may increase the risk of certain bacterial infections; if diarrhea or infection symptoms persist during use, immediately inform healthcare professionals. Caution is necessary as drowsiness may occur during driving or operating machinery. There is no specific antidote for overdose, so treatment should be provided according to symptoms. Do not chew or crush the tablet; swallow it whole. When storing, keep it in a tightly closed container to prevent air or moisture ingress, and do not transfer it to another container.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, prolonged QT interval, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, blood in stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, dry mouth, vomiting, lower abdominal pain, stomach body, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal hemorrhage, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbance, tremors, weakness, neurosensitivity, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, excessive blood volume, muscle weakness of the limbs, sensory impairment, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccup, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin discoloration, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, ocular pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, malaise, weight gain, visual disturbances, anorexia, neck stiffness, photosensitivity reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonaemia, rhabdomyolysis, delirium, vascular edema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, arthralgia, epileptic nephritis, gynecomastia, elevated thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, discoid lupus erythematosus, halitosis, dry mouth, increased intraocular pressure, palpitations, facial swelling, flushing, dizziness, tingling in hands and feet, allergic reaction, chest tightness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture ingress. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius, as this helps to maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu pack x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.